AHNAK2 and neoplasm: It was also reported that AHNAK2 mutation remodeled the tumor microenvironment, including elevating the infiltration of M1 macrophages, B cells, and fibroblasts, leading to impaired response to chemotherapy (Ye et al., 2024).